Connection
Nirmal Banda to Complement C3 Convertase, Alternative Pathway
This is a "connection" page, showing publications Nirmal Banda has written about Complement C3 Convertase, Alternative Pathway.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.161 |
|
|
|
-
Fridkis-Hareli M, Storek M, Or E, Altman R, Katti S, Sun F, Peng T, Hunter J, Johnson K, Wang Y, Lundberg AS, Mehta G, Banda NK, Michael Holers V. The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models. Mol Immunol. 2019 01; 105:150-164.
Score: 0.161